INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 135 filers reported holding INTRA CELLULAR THERAPIES INC in Q3 2016. The put-call ratio across all filers is 0.81 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $295,000 | +39.8% | 7,600 | 0.0% | 0.12% | +34.1% |
| Q1 2016 | $211,000 | -48.4% | 7,600 | 0.0% | 0.09% | -23.5% |
| Q4 2015 | $409,000 | -95.0% | 7,600 | -96.3% | 0.12% | -92.7% |
| Q3 2015 | $8,235,000 | -28.2% | 205,657 | -42.7% | 1.58% | +45.8% |
| Q2 2015 | $11,465,000 | +31.4% | 358,857 | -1.8% | 1.08% | +31.1% |
| Q1 2015 | $8,725,000 | +33.3% | 365,357 | -1.5% | 0.82% | +31.4% |
| Q4 2014 | $6,544,000 | +28.3% | 370,757 | -0.3% | 0.63% | +19.2% |
| Q3 2014 | $5,100,000 | -23.1% | 371,957 | -5.4% | 0.53% | -7.6% |
| Q2 2014 | $6,630,000 | -7.5% | 393,257 | -0.3% | 0.57% | -2.7% |
| Q1 2014 | $7,169,000 | – | 394,357 | – | 0.58% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 700,000 | $42,833,000 | 8.57% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 308,819 | $18,897,000 | 7.82% |
| Vahanian & Associates Financial Planning Inc. | 45,533 | $2,786,000 | 6.44% |
| DCF Advisers, LLC | 238,500 | $14,594,000 | 6.39% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 50,956 | $20,930,000 | 4.72% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,531,923 | $93,738,000 | 2.86% |
| Nicholas Investment Partners, LP | 562,373 | $34,412,000 | 2.45% |
| Bellevue Group AG | 3,429,619 | $209,859,000 | 2.44% |
| WASATCH ADVISORS LP | 7,477,868 | $457,571,000 | 2.25% |
| Quantum Private Wealth, LLC | 73,772 | $4,514,000 | 1.95% |